Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT05711992

Recruiting

Rare Embryonal Tumors of the Central Nervous System: International Registry

Embryonal Tumor
NCT05661188

Recruiting

Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS) (TIRANUS)

Squamous Cell Carcinoma of the Anal Canal
NCT05590533

Not yet recruiting

Turkish Version of F-2-MS

Multiple Sclerosis | Fatigue | Reliability | Validity | Cultural Adaptation
NCT05516537

Completed

Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments. (TEAAMS)

Multiple Sclerosis
NCT04544436

Active, not recruiting

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) (MUSETTE)

Multiple Sclerosis
NCT07504783

Active, not recruiting

A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab

Multiple Sclerosis
NCT04353492

Completed

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab (ARTIOS)

Relapsing Multiple Sclerosis
NCT04075266

Active, not recruiting

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis
NCT05131828

Completed

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Multiple Sclerosis
NCT05469568

Active, not recruiting

Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT03958877

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT03535298

Active, not recruiting

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS (DELIVER-MS)

Multiple Sclerosis, Relapsing-Remitting
NCT07123337

Completed

Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis (EDSS)

Multiple Sclerosis
NCT06061939

Completed

Effects of Blood Flow Restriction Training on Middle-aged People With Multiple Sclerosis.

Sclerosis, Multiple
NCT06475183

Completed

Probiotic Chocolate Study in Multiple Sclerosis (ProChocolate)

Multiple Sclerosis | Healthy Nutrition
NCT04639401

Completed

Auditory-motor Coupling in Multiple Sclerosis with Cerebellar Lesions

Multiple Sclerosis | Cerebral Lesion
NCT04025554

Completed

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Multiple Sclerosis
NCT03206177

Completed

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

Carcinosarcoma, Ovarian
NCT02747914

Suspended

Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis Patients

Multiple Sclerosis
NCT04389970

Completed

Time Restricted Eating Outcomes in Multiple Sclerosis (TREO_MS)

Multiple Sclerosis | Diet, Healthy
NCT04011579

Completed

Pilates Training in Multiple Sclerosis (MS-FIT)

Multiple Sclerosis | Physical Activity
NCT06220409

Completed

Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients (MSDANCE)

Sclerosis, Multiple
NCT05735067

Active, not recruiting

The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients

Multiple Sclerosis
NCT01345838

Completed

Acetabular Labral Tear in Dysplastic Hips

Developmental Dysplasia of the Hip | Labrum
NCT04966338

Completed

Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis | Relapsing-Remitting
NCT04555863

Completed

haMSter: a Novel Smartphone Communication Tool for People With MS

Multiple Sclerosis | M-health
NCT03566251

Completed

Core Stability, Trunk Position Sense, Balance and Functional Mobility in Patients With Multiple Sclerosis

Physical Therapy
NCT01359566

Completed

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

Multiple Sclerosis
NCT02290444

Completed

Effects of Acthar on Recovery From Cognitive Relapses in MS

Multiple Sclerosis
NCT04237337

Unknown

Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase (PVSEPK)

Multiple Sclerosis | Malignant Tumor
NCT03887507

Completed

Vojta Therapy in Multiple Sclerosis.

Multiple Sclerosis | Physical Therapy
NCT03785483

Unknown

Implementation Intention for Physical Activity in Multiple Sclerosis (apsep)

Motivation | Mindfulness
NCT01356940

Completed

A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis

Multiple Sclerosis
NCT01871818

Completed

A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients (REHABMUSCLE)

Multiple Sclerosis
NCT02471222

Completed

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Multiple Sclerosis | Walking Impairment
NCT02463318

Completed

The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects

Multiple Sclerosis | Oxidative Stress
NCT00938366

Completed

Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects

Multiple Sclerosis
NCT00638027

Completed

Memantine for Spasticity in MS Patients

Multiple Sclerosis
NCT01207648

Completed

Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY) (REPLAY)

Multiple Sclerosis
NCT02331654

Unknown

Spinal Direct Current Stimulation Effects on Pain in Multiple Sclerosis

Multiple Sclerosis
NCT00764413

Terminated

Chronotherapy in Acute Multiple Sclerosis (MS) Attack

Multiple Sclerosis
NCT01142557

Completed

An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis

Multiple Sclerosis
NCT00001934

Completed

Zenapax to Treat Multiple Sclerosis

Multiple Sclerosis
NCT00688948

Terminated

Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

Multiple Sclerosis | Bladder Dysfunction
NCT00079495

Completed

Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

Multiple Sclerosis
NCT06202339

Not yet recruiting

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Carcinoma of the Vulva | Recurrent Carcinoma of the Vulva
NCT04724018

Recruiting

Sacituzumab Govitecan Plus EV in Metastatic UC

Bladder Cancer | Urothelial Cancer | Metastatic Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter
NCT01118039

Unknown

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
NCT00006026

Completed

Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
NCT04002817

Completed

Giant Cell Tumor of the Bone in Young Patients

Giant Cell Tumor of Bone

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations